New antiepileptic drugs

被引：50

作者：

Patsalos, PN

机构：

[1] UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Dept Clin Neurol, Pharmacol & Therapeut Unit, London WC1N 3BG, England

[2] Chalfont Ctr Epilepsy, Natl Soc Epilepsy, Gerrards Cross SL9 0RJ, Bucks, England

来源：

ANNALS OF CLINICAL BIOCHEMISTRY | 1999年 / 36卷

关键词：

epilepsy; pharmacokinetics; therapeutic drug monitoring; drug interactions; novel mechanisms of action;

D O I：

10.1177/000456329903600102

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：10 / 19

页数：10

共 56 条

[1] GABAPENTIN (NEURONTIN) AS ADD-ON THERAPY IN PATIENTS WITH PARTIAL SEIZURES - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].

ANHUT, H ;

ASHMAN, P ;

FEUERSTEIN, TJ ;

SAUERMANN, W ;

SAUNDERS, M ;

SCHMIDT, B ;

BAUER, G ;

DEISENHAMMER, E ;

KLINGLER, D ;

MAMOLI, B ;

GRAF, M ;

DANTA, G ;

BERKOVIC, S ;

VAJDA, F ;

BUCHANAN, N ;

SCHAPEL, G ;

BLACK, A ;

BAJADA, S ;

DEBARSY, T ;

LATERRE, C ;

VANZANDIJCKE, M ;

MCLACHLAN, RS ;

PURVES, SJ ;

LEE, MA ;

BRUNI, J ;

GAWEL, M ;

HOLTLARSEN, B ;

WERDELIN, L ;

DALBY, MA ;

IIVANAINEN, MV ;

GIROUD, M ;

LECLERCQ, E ;

REMY, C ;

SALLOU, C ;

RICHENS, A ;

BILL, PLA .

EPILEPSIA, 1994, 35 (04) :795-801

[2] Vigabatrin serum concentration to dosage ratio: Influence of age and associated antiepileptic drugs [J].

Armijo, JA ;

Cuadrado, A ;

Bravo, J ;

Arteaga, R .

THERAPEUTIC DRUG MONITORING, 1997, 19 (05) :491-498

[3] GAMMA-VINYL GABA (VIGABATRIN) - RELATIONSHIP BETWEEN DOSAGE, PLASMA-CONCENTRATIONS, PLATELET GABA-TRANSAMINASE INHIBITION, AND SEIZURE REDUCTION IN EPILEPTIC CHILDREN [J].

ARTEAGA, R ;

HERRANZ, JL ;

VALDIZAN, EM ;

ARMIJO, JA .

EPILEPSIA, 1992, 33 (05) :923-931

[4] The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: A prospective study with preliminary assessment of correlations with clinical response [J].

Bartoli, A ;

Guerrini, R ;

Belmonte, A ;

Alessandri, MG ;

Gatti, G ;

Perucca, E .

THERAPEUTIC DRUG MONITORING, 1997, 19 (03) :252-260

[5] THE EFFECT OF DIFFERENT VIGABATRIN TREATMENT REGIMENS ON CSF BIOCHEMISTRY AND SEIZURE CONTROL IN EPILEPTIC PATIENTS [J].

BENMENACHEM, E ;

PERSSON, LI ;

SCHECHTER, PJ ;

HAEGELE, KD ;

HUEBERT, N ;

HARDENBERG, J ;

DAHLGREN, L ;

MUMFORD, JP .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 :S79-S85

[6]

BERRY DJ, 1998, EPILEPSIA S2, V39, P67

[7] Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy [J].

Beydoun, A ;

Fakhoury, T ;

Nasreddine, W ;

Abou-Khalil, B .

EPILEPSIA, 1998, 39 (02) :188-193

[8] DRUG CONCENTRATION MONITORING - AN APPROACH TO RATIONAL USE [J].

BROWN, GR ;

MIYATA, M ;

MCCORMACK, JP .

CLINICAL PHARMACOKINETICS, 1993, 24 (03) :187-194

[9] VIGABATRIN FOR REFRACTORY COMPLEX PARTIAL SEIZURES - MULTICENTER SINGLE-BLIND STUDY WITH LONG-TERM FOLLOW-UP [J].

BROWNE, TR ;

MATTSON, RH ;

PENRY, JK ;

SMITH, DB ;

TREIMAN, DM ;

WILDER, BJ ;

BENMENACHEM, E ;

NAPOLIELLO, MJ ;

SHERRY, KM ;

SZABO, GK .

NEUROLOGY, 1987, 37 (02) :184-189

[10] LAMOTRIGINE (BW430C), A POTENTIAL ANTICONVULSANT - EFFECTS ON THE CENTRAL NERVOUS-SYSTEM IN COMPARISON WITH PHENYTOIN AND DIAZEPAM [J].

COHEN, AF ;

ASHBY, L ;

CROWLEY, D ;

LAND, G ;

PECK, AW ;

MILLER, AA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (06) :619-629

← 1 2 3 4 5 6 →